Sign in

CIK 0001841330

  • Emerging growth company

Pasithea Therapeutics Corp.

Sign in to watch
Ticker
KTTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851591963
Phone
+1 702-514-4174
Business address
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
  1. 4 Open-market buy Director bought 30,000 shares at $0.43 ($12,930)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 5,000 shares (grant or award)
  4. 4 Grant or award Chief Executive Officer acquired 9,206 shares (grant or award)
  5. 4 Grant or award Director acquired 5,000 shares (grant or award)
  6. 4 Grant or award Director acquired 50,000 shares (grant or award)
  7. 4 Grant or award Director acquired 5,000 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
  10. 4 Open-market buy Member of 10% owner group bought 1,000 shares at $1.11 ($1,110)
  11. 4 Grant or award Director acquired 10,000 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market buy Member of 10% owner group bought 64,357 shares at an average $1.19 ($76,299)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Member of 10% owner group bought 88,901 shares at an average $1.13 ($100,367)
  16. 4 Open-market buy Member of 10% owner group bought 22,828 shares at an average $1.15 ($26,293)
  17. 4 Open-market buy Member of 10% owner group bought 54,644 shares at $1.30 ($70,939)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy Member of 10% owner group bought 155,773 shares at $1.21 ($188,283)
  20. 3 Insider Initial Statement of Ownership

Page 3 of 5 · 81 filings